Stortz, M.; Triantafyllias, K.; Schwarting, A. et al.
Vascular stiffness: influencing factors on carotid-femoral pulse wave velocity in systemic lupus erythematosusCLINICAL AND EXPERIMENTAL RHEUMATOLOGY. Bd. 38. H. 1. 2020 S. 74-81
Smyth, Elizabeth; Knoedler, Maren; Giraut, Anne et al.
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-StudyFRONTIERS IN ONCOLOGY. Bd. 9. 2020
Huber, Yvonne; Galle, Peter R.; Schattenberg, Joern M.
What is the (right) target for non-alcoholic fatty liver disease (NAFLD)?ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 58. H. 1. 2020 S. 68-73
Marquard, Simone; Thomann, Stefan; Weiler, Sofia M. E. et al.
Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesisCELL COMMUNICATION AND SIGNALING. Bd. 18. H. 1. 2020
Moore, Assaf; Hikri, Elad; Goshen-Lago, Tal et al.
Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?BMC CANCER. Bd. 20. H. 1. 2020
Ishaq, Sauid; Siau, Keith; Lee, Minhong et al.
Zenker's Diverticulum: Can Protocolised Measurements with Barium SWALLOW Predict Severity and Treatment Outcomes? The "Zen-Rad" StudyDYSPHAGIA. 2020
Harrison, Stephen A.; Goodman, Zachary D.; Jabbar, Abdul et al.
A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF EMRICASAN IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSISHEPATOLOGY. Bd. 70. 2019 S. 43A-44A
van Keulen, Kelly E.; Neumann, Helmut; Schattenberg, Joern M. et al.
A novel device for intracolonoscopy cleansing of inadequately prepared colonoscopy patients: a feasibility studyENDOSCOPY. Bd. 51. H. 1. 2019 S. 85-92
Hofmann, Michael; Thieringer, Florian; Mai Ahn Nguyen, ? et al.
A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulationsEUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. Bd. 136. 2019 S. 192-202
Kelley, R. K.; Gane, E.; Assenat, E. et al.
A Phase 2 Study of Galunisertib (TGF-beta 1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular CarcinomaCLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. Bd. 10. 2019